<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">350707</id>
  <title nil="true"/>
  <common-name>3-[4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazin-1-yl]propyl 2-hydroxy-2-phenylacetate</common-name>
  <description>3-[4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazin-1-yl]propyl 2-hydroxy-2-phenylacetate is a chemical compound with the formula C30H34N2O3S2. With an average molecular weight of 534.70 g/mol, 3-[4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazin-1-yl]propyl 2-hydroxy-2-phenylacetate is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>3070442</pubchem-id>
  <chemical-formula>C30H34N2O3S2</chemical-formula>
  <weight>534.7</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T15:56:31Z</created-at>
  <updated-at type="dateTime">2026-08-31T15:56:31Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CSC1=CC2=C(C=C1)SC3=CC=CC=C3CC2N4CCN(CC4)CCCOC(=O)C(C5=CC=CC=C5)O</moldb-smiles>
  <moldb-formula>C30H34N2O3S2</moldb-formula>
  <moldb-inchi>InChI=1S/C30H34N2O3S2/c1-36-24-12-13-28-25(21-24)26(20-23-10-5-6-11-27(23)37-28)32-17-15-31(16-18-32)14-7-19-35-30(34)29(33)22-8-3-2-4-9-22/h2-6,8-13,21,26,29,33H,7,14-20H2,1H3</moldb-inchi>
  <moldb-inchikey>PHVYVZXSCBFCJO-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">534.2010853</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>5.5</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM346600</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>3-[4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazin-1-yl]propyl 2-hydroxy-2-phenylacetate</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzothiepins</klass>
  <subklass>Dibenzothiepins</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0301012</sync-id>
  <structure-inchikey>PHVYVZXSCBFCJO-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>4004000000000000002080000010080000001000000000000040000011000000000000000000000000000000000100040424000000000000000000000000000000000400000000000000000000000000002400001000010001000000008000000000000001100000000000000010000000000002010004000000080000000010100000004008000080000000000000404000000000010000000008000100000000000000840000000000040008000100000000000000000000a000000040000000000000000440000000000000000000000000000008801002800200000000010000000000000042000040000000010400000000000000001000000000000008</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAlAAAAKQAAAIABBgBgAAAAAQMQACAAAAAC
BkAoAAAAAwQGQGgAAAADAwEGQCgAAAADBAZAKAAAAAMEBkBoAAAAAwMBBkBo
AAAAAwMBEAAgAAAAAgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkBoAAAA
AwMBBkBoAAAAAwMBBkAoAAAAAwQGAGAAAAACAgYAYAAAAAMBBwAgAAAAAwYA
YAAAAAICBgBgAAAAAgIHACAAAAADBgBgAAAAAgIGAGAAAAACAgYAYAAAAAIC
BgBgAAAAAgIGAGAAAAACAggAKAAAAAMCBgAoAAAAAwQIACgAAAADAgYAYAAA
AAMBBkAoAAAAAwQGQGgAAAADAwEGQGgAAAADAwEGQGgAAAADAwEGQGgAAAAD
AwEGQGgAAAADAwEIAGAAAAABAQsAAQABAgACA2gMAwRoDAQFaAwFBmgMBgdo
DAUIAAgJAAkKaAwKC2gMCwxoDAwNaAwNDmgMDg8ADxAAEBEAERIAEhMAExQA
FBUAFRYAFBcAFxgAGBkAGRoAGhsgGxwoAhsdAB0eAB4faAwfIGgMICFoDCEi
aAwiI2gMHSQABwJoDBAEAA4JaAwWEQAjHmgMQgUAAAAGAgcGBQQDBwgFBBAP
DgkGCgsMDQ4JBhITFBUWEQYfICEiIx4XBAAAAAAAAAAW
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:48:42Z</structure-indexed-at>
</compound>
